About 60,000 US Breast Cancer Patients Can Skip Chemotherapy: Study The TAILORx study showed that the genomic test Oncotype DX can help determine if a breast cancer patient can safely get hormone therapy alone. Who can skip chemotherapy? by Allan Adamson